These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3161086)

  • 1. Selective decontamination of the digestive tract by norfloxacin. A preliminary report.
    Pecquet SS; Andremont AO; Tancrède CH
    Prog Clin Biol Res; 1985; 181():255-8. PubMed ID: 3161086
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of selective decontamination of the gi-tract of mice on the survival of intestinal mucosa during X-irradiation.
    Toorop-Bouma AG; Van der Waaij D
    Prog Clin Biol Res; 1985; 181():271-3. PubMed ID: 3161088
    [No Abstract]   [Full Text] [Related]  

  • 3. Norfloxacin for selective decontamination: a study in human volunteers.
    De Vries-Hospers HG; Welling GW; Van der Waaij D
    Prog Clin Biol Res; 1985; 181():259-62. PubMed ID: 3161087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decontamination of the digestive tract of pregnant rabbits: a method for producing Enterobacteriaceae-free rabbits.
    Heidt PJ; Timmermans CP
    Lab Anim Sci; 1975 Oct; 25(5):594-6. PubMed ID: 127074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
    van Saene JJ; van Saene HK; Stoutenbeek CP; Lerk CF
    Scand J Infect Dis; 1985; 17(3):295-300. PubMed ID: 2932792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
    Frimodt-Møller PC; Jensen KM; Madsen PO
    Antimicrob Agents Chemother; 1983 Oct; 24(4):560-3. PubMed ID: 6228191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and rats.
    Koopman JP; Kennis HM; Stadhouders AM; de Boer H
    Z Versuchstierkd; 1984; 26(5):197-204. PubMed ID: 6334949
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
    Coll R; Esteve M; Moros M; Xicota MA; Parés J
    Drugs Exp Clin Res; 1987; 13(2):75-7. PubMed ID: 3582134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial action of norfloxacin].
    Fabio U; Provvisionato CA; Tampieri A; Quaglio GP
    G Ital Chemioter; 1983; 30(1):53-9. PubMed ID: 6229443
    [No Abstract]   [Full Text] [Related]  

  • 13. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of norfloxacin against multi-resistant bacteria.
    Machka K; Vogelsang G
    Eur J Clin Microbiol; 1983 Jun; 2(3):270-1. PubMed ID: 6224686
    [No Abstract]   [Full Text] [Related]  

  • 16. Cleavage of lactose-lysine, a novel indicator of colonization resistance of the digestive tract.
    Welling GW; Groen G
    Prog Clin Biol Res; 1985; 181():151-4. PubMed ID: 4022970
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioassay procedures for norfloxacin.
    Bland J; Edison A; Huber J
    Eur J Clin Microbiol; 1983 Jun; 2(3):249-52. PubMed ID: 6224682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective decontamination of the digestive tract for the prevention of infection in patients with neutropenia].
    Bláha M; Vacková M; Vanásek J; Splino M; Jebavý L; Malý J; Pecka M
    Vnitr Lek; 1986 Aug; 32(8):790-6. PubMed ID: 3765417
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit.
    Abecasis F; Kerr S; Sarginson RE; Silvestri L; de la Cal MA; Zandstra D; Beishuizen A; Damjanovic V; van Saene HK
    J Antimicrob Chemother; 2007 Aug; 60(2):445; author reply 446. PubMed ID: 17584803
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E; Garcia J; Vila B; Santos M; Gobernado M
    Microbiol Esp; 1984; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.